Drug Profile
Research programme: obesity therapeutics - Bioobesity/Jin Yang Pharmaceutical
Latest Information Update: 08 Jul 2016
Price :
$50
*
At a glance
- Originator BioObesity; Jin Yang Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Obesity